The presence of MDM4 amplification and breakage-fusion-bridge (BFB)–driven chromosomal instability may confer resistance to melphalan.16,19 Instead, this tumor responded much better to topotecan, a topoisomerase I inhibitor that induces replication stress—a mechanism potentially more effective in genomically unstable tumors.12 Here, MDM4 is linked to neoplasm.